Limited research studies with a large sample size were performed to evaluate the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for in-hospital or long-term poor outcomes in patients with infective endocarditis.
Methods
A total of 703 patients with infective endocarditis were enrolled and divided into four groups according to admission NT-pro-BNP (pg/mL) quartiles: Q1 (<258), Q2 (258–1054), Q3 (1055–3522) and Q4 (>3522). Multivariate regression was used to determine independent risk of NT-proBNP for in-hospital and one-year death.
Results
In-hospital death occurred in 9.0% of patients. The in-hospital mortality was increased from the lowest to the highest NT-proBNP quartiles (1.1%, 3.4%, 9.1% and 22.3%, P < 0.001, respectively). During the one-year follow-up period, 29 patients died: 0 in Q1, 7 (4.6%) in Q2, 8 (5.7%) in Q3 and 14 (12.0%) in Q4 (P < 0.001). Log-transformed (lg) NT-proBNP had a linear correlation with lg C-reactive protein (r = 0.308, P < 0.001). Multivariate analysis showed lgNT-proBNP was an independent predictor for both in-hospital (odds ratio 4.59, 95% confidence interval (CI) 2.45–8.61, P < 0.001) and one-year mortality (hazard ratio 3.11, 95% CI 1.65–5.87, P < 0.001). In addition, NT-proBNP had a higher predictive power for in-hospital death than C-reactive protein (area under the curve 0.797 vs. 0.670, P = 0.005). NT-proBNP > 2260 pg/mL had 76.2% sensitivity and 69.1% specificity for predicting in-hospital death. Kaplan–Meier analysis showed that patients with NT-proBNP > 2260 pg/ml had a worse prognosis than those without (log-rank test 18.84, P < 0.001).
Conclusion
Increased NT-proBNP was independently associated with in-hospital and one-year mortality in patients with infective endocarditis.
HabibGLancellottiPAntunesMJ. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J2015; 36: 3075–3128.
2.
TernhagACederstromATornerA. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLOS ONE2013; 8: e67519–e67519.
3.
ThunyFGiorgiRHabachiR. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J2012; 164: 94–101.
4.
Fernandez-HidalgoNAlmiranteBTornosP. Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect2012; 18: E522–E530.
5.
HeiroMHeleniusHHurmeS. Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years. BMC Infect Dis2008; 8: 49–49.
6.
MokhlesMMCiampichettiIHeadSJ. Survival of surgically treated infective endocarditis: a comparison with the general Dutch population. Ann Thorac Surg2011; 91: 1407–1412.
7.
YasueHYoshimuraMSumidaH. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation1994; 90: 195–203.
8.
XiaWJHuangYYChenYL. Acute myocardial ischemia directly modulates the expression of brain natriuretic peptide at the transcriptional and translational levels via inflammatory cytokines. Eur J Pharmacol2011; 670: 7–12.
9.
SavareseGMusellaFD’AmoreC. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis. JACC Heart Fail2014; 2: 148–158.
10.
WindhausenFHirschASandersGT. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. Am Heart J2007; 153: 485–492.
11.
BrueckmannMHuhleGLangS. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation2005; 112: 527–534.
12.
YoungYRSheuBFLiWC. Predictive value of plasma brain natriuretic peptide for postoperative cardiac complications – a systemic review and meta-analysis. J Crit Care2014; 29: 691–696.
13.
LiuYHLiuYZhouYL. Association of N-terminal pro-B-type natriuretic peptide with contrast-induced nephropathy and long-term outcomes in patients with chronic kidney disease and relative preserved left ventricular function. Medicine (Baltimore)2015; 94: e358–e358.
14.
PastormerloLEMaffeiSLattaDD. N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives. Eur J Prev Cardiol2016; 23: 366–376.
15.
ShiueABStancovenABPurcellJB. Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis. Am J Cardiol2010; 106: 1011–1015.
16.
KahveciGBayrakFMutluB. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis. Am J Cardiol2007; 99: 1429–1433.
17.
SicilianoRFGualandroDMMuellerC. Incremental value of B-type natriuretic peptide for early risk prediction of infective endocarditis. Int J Infect Dis2014; 29: 120–124.
18.
LiJSSextonDJMickN. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis2000; 30: 633–638.
19.
MaYCZuoLChenJH. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol2006; 17: 2937–2944.
20.
DeLongERDeLongDMClarke-PearsonDL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics1988; 44: 837–845.
21.
ParkLPChuVHPetersonG. Validated risk score for predicting 6-month mortality in infective endocarditis. J Am Heart Assoc2016; 5: e3016–e3016.
22.
LeoneSRavasioVDurante-MangoniE. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection2012; 40: 527–535.
23.
BannayAHoenBDuvalX. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?Eur Heart J2011; 32: 2003–2015.
24.
KangDHKimYJKimSH. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med2012; 366: 2466–2473.
KleinMWangA. Infective endocarditis. J Intens Care Med2016; 31: 151–163.
27.
BansalNKatzRDalrympleL. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults. Clin J Am Soc Nephrol2015; 10: 205–214.
28.
MishraRKLiYRicardoAC. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). Am J Cardiol2013; 111: 432–438.
29.
LyngbaekSWinkelPGotzeJP. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide. Eur J Prev Cardiol2014; 21: 1275–1284.
30.
van KimmenadeRRJanuzziJJBakkerJA. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol2009; 53: 884–890.
31.
KloucheKPommetSAmiguesL. Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality. J Intens Care Med2014; 29: 229–237.
32.
ChenYLiC. Prognostic significance of brain natriuretic peptide obtained in the ED in patients with SIRS or sepsis. Am J Emerg Med2009; 27: 701–706.
33.
SatoRNasuM. A review of sepsis-induced cardiomyopathy. J Intens Care2015; 3: 48–48.
34.
PostFWeilemannLSMessowCM. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Crit Care Med2008; 36: 3030–3037.
35.
KrishnagopalanSKumarAParrilloJE. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care2002; 8: 376–388.
36.
TomaruKKAraiMYokoyamaT. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol2002; 34: 649–659.
37.
HeiroMHeleniusHSundellJ. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J2005; 26: 1873–1881.
